Medibell has developed a number of advanced eye scanning devices.
Sources inform ''Globes'' that Medibell Vision Technologies Ltd., which develops specialized cameras for eye screening, has begun its road show ahead of its IPO on the Tel Aviv Stock Exchange (TASE), which will be led by underwriter Poalim IBI Ltd.
Medibell was founded in 1999 and has received $7-8 million in financing to date, mostly from CMT Medical Technologies (Paris: CMD.PA). CMT posted sales of $23 million in 2005 and it is profitable. Medibell aims to reach breakeven by the end of 2007. It made the first sales of its flagship product two years ago and launched two newer more advanced devices in 2006.
Medibell focuses on eye screening for the diagnosis of diseases such as age-related macular degeneration, glaucoma, and damage caused by diabetic retinopathy.
“Globes” writer and commentator Shlomo Greenberg is one of the owners of CMT.
Published by Globes [online], Israel business news - www.globes.co.il - on January 31, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007